Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
45.50
-0.32 (-0.70%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Belite Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Belite Bio stock have an average target of 50.25, with a low estimate of 25 and a high estimate of 60. The average target predicts an increase of 10.44% from the current stock price of 45.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Belite Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +29.67% | Jun 13, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +25.27% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +29.67% | May 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.75M
EPS This Year
-1.05
from -1.19
EPS Next Year
-0.80
from -1.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 52.5M | 76.0M | 130.4M | 270.4M |
| Avg | n/a | 12.8M | 49.7M | 94.0M | 202.4M |
| Low | n/a | n/a | 24.5M | 56.8M | 121.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 496.2% | 162.5% | 187.6% |
| Avg | - | - | 289.6% | 89.2% | 115.3% |
| Low | - | - | 92.2% | 14.4% | 29.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.95 | 0.11 | 0.05 | 0.89 | 4.43 |
| Avg | -1.05 | -0.80 | -0.15 | 0.74 | 3.46 |
| Low | -1.08 | -1.26 | -0.34 | 0.59 | 2.51 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 499.2% |
| Avg | - | - | - | - | 367.6% |
| Low | - | - | - | - | 239.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.